By 2050, around 2 million people — the majority aged over 70 — could die from drug-resistant infections each year.

NovoBind's technology has shown promise in addressing major diseases like acute hepatopancreatic necrosis (AHPND) in shrimp

03-Sep-2024 By Nicholas Robinson Food and drink suppliers will face increased scrutiny as 80 of the world’s biggest investors today join...